Study objectives: To investigate the clinical, epidemiologic, and microbiological characteristics of community-acquired pneumonia (CAP) due to Acinetobacter baumannii. Methods: Retrospective chart and radiographic reviews of all patients who were admitted to National Taiwan University Hospital from January 1993 to August 1999, fulfilled the criteria for CAP, and had an isolate of A baumannii from blood or pleural fluid at hospital admission. Results: Thirteen patients (9 men and 4 women; age range, 37 to 85 years) met the criteria. Conditions associated with the infection included male gender, old age, alcoholism, malignancy, cerebrovascular disease, diabetes mellitus, renal disease, and liver cirrhosis. Eleven patients (85%) acquired the infection during the warmer months of April to October. Twelve patients (92%) had a fulminant course presenting with septic shock and respiratory failure, and 11 patients (85%) needed ventilator support and were treated in an ICU. Six patients (46%) had leukopenia. Lobar consolidations were found in 12 patients (92%), and pleural effusions were present in 4 patients (31%). All patients had positive blood culture results, two patients (15%) had positive pleural effusion culture findings, and nine patients (69%) positive sputum culture results. All the isolates were susceptible to imipenem, and most were susceptible to aminoglycosides, ceftazidime, ciprofloxacin, and extended-spectrum penicillins. Eight patients (62%) died. Four of the five survivors were initially treated with combination of a third-generation cephalosporin and an aminoglycoside. A cinetobacter baumannii, an aerobic Gramnegative coccobacillus, is ubiquitous in fresh water and soil. As a frequent skin and oropharyngeal commensal, 1 it is also a well-recognized pathogen causing nosocomial pneumonia, predominantly in patients with endotracheal intubation, prolonged mechanical ventilation, underlying lung diseases, prior broadspectrum antibiotic treatment, recent major surgery,
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enteric feeding, or who are being treated in an ICU. [2] [3] [4] Community-acquired pneumonia (CAP) due to A baumannii is uncommon. There have been 86 cases since the first case was reported Ͼ 30 years ago. [5] [6] [7] [8] [9] [10] [11] Most of the reported cases were associatedwith underlying conditions (including alcoholism, smoking, COPD, and diabetes mellitus) and high mortality (from 40 to 64%). [5] [6] [7] [8] [9] [10] [11] However, several prospective studies [12] [13] [14] did not consider A baumannii an important pathogen causing severe CAP. In the present study, we describe 13 patients with community-acquired bacteremic pneumonia caused by A baumannii, emphasize the fulminant nature of this infection, and discuss the appropriate empirical antimicrobial therapy.
Materials and Methods

Patients
We searched the computer database of our microbiology laboratory for patients with positive blood or pleural effusion culture findings for A baumannii between January 1993 and August 1999. We then reviewed the hospital records of these patients and determined if they fulfilled the criteria for entering the study. The criteria for inclusion in the study included: (1) a positive blood or pleural effusion culture finding for A baumannii obtained at the emergency service immediately after arrival, or at the ward immediately after hospital admission; (2) a clinical course compatible with the diagnosis of pneumonia, including symptoms of acute respiratory infection (fever or hypothermia, rigors, new cough, change of color of sputum, chest pain, and dyspnea) and acute infiltrates on chest radiograph; (3) pneumonia acquired outside a hospital or nursing home; and (4) no hospitalization in the month before the development of pneumonia. 15 We then analyzed each patient's clinical course, radiologic patterns, treatment, and outcome.
Severe CAP was diagnosed if at least one of the following conditions was present: (1) respiratory rate Ͼ 30 breaths/min at hospital admission; (2) respiratory failure, with Pao 2 Ͻ 60 mm Hg with the patient breathing room air, a Pao 2 /fraction of inspired oxygen (Fio 2 ) ratio Ͻ 250 mm Hg, a change of consciousness associated with cyanosis, or a need for mechanical ventilation 16 -18 ; (3) chest radiograph showing involvement of multiple lobes; (4) shock (systolic BP Ͻ 90 mm Hg or diastolic BP Ͻ 60 mm Hg); (5) vasopressor requirement for Ͼ 4 h; and (6) urine output Ͻ 20 mL/h, or total urine output Ͻ 80 mL in 4 h in the absence of other causes, or acute renal failure requiring dialysis. 18 
Statistical Analysis
Fisher's Exact Probability Test was used to compare mortality, underlying condition, clinical presentation, and effective antibiotics between various groups of patients. A p value Ͻ 0.05 was considered statistically significant.
Results
Only 13 of the 373 patients (9 men and 4 women) with A baumannii isolated from their blood or pleural effusion had CAP diagnosed during the study period. All A baumannii-positive culture results from these 13 patients were obtained at the time of arrival at the emergency department or on hospital admission. Blood cultures were obtained from only 7 to 8% of the approximately 700 patients with CAP visiting our emergency service annually. Thus, our 13 patients represent about 0.3% of patients with a diagnosis of CAP, or approximately 3.7% of patients whose blood was cultured in the approximate 6.5-year study period. All 13 patients had positive blood culture results, and 2 patients also had positive pleural effusion findings. Eleven patients acquired the pneumonia between April and October (two patients acquired the pneumonia in December). The clinical data of the 13 patients are summarized in Table 1 .
The mean age of the 13 patients was 64 years (range, 37 to 85 years). Ten patients (77%) were Ͼ 60 years old. All three of the younger patients were alcoholics. The mean age of the alcoholic patients was 47 years, in contrast to that of the nonalcoholic patients (mean, 71 years; p Ͻ 0.001). Every patient had an underlying disease, including alcoholism (n ϭ 4), lung cancer (n ϭ 4), diabetes mellitus (n ϭ 4), cerebrovascular disease (n ϭ 4), renal insufficiency (n ϭ 3), liver cirrhosis (n ϭ 2), and lymphoma (n ϭ 1). Four patients were smokers. None of the patients had received antibiotics or steroids prior to hospital admission.
Common presentations were abrupt onset of fever (n ϭ 11), shock (n ϭ 11), cough (n ϭ 12) with purulent (n ϭ 7) or bloodstained (n ϭ 4) sputum, dyspnea (n ϭ 10), and drowsiness (n ϭ 6). Four patients had pleuritic pain. The median duration of symptoms was 3 days (range, 1 to 14 days). On arrival at the emergency department, 12 patients (all patients but patient 7) had respiratory failure or shock, and 11 of these patients were immediately admitted to the ICU. They were categorized as having severe CAP. The CAP of patient 7 was also considered severe owing to radiographic evidence of involvement of three lobes. The 11 A baumannii-infected patients sent to the ICU constitute 2% of the 502 patients with severe CAP who were admitted to ICU in the same period.
The initial arterial oxygen saturation levels were unknown because high-flow oxygen had to be administered immediately on arrival. The mean Pao 2 /Fio 2 ratio was 207.4 mm Hg; 8 of 13 patients (62%) had Ͻ 250 mm Hg. The mean Pao 2 /Fio 2 ratio of the patients who eventually died was 173 mm Hg, and that of the survivors was 263 (p ϭ 0.229). The APACHE (acute physiology and chronic health evaluation) II scores ranged from 7 to 46 (mean, 25). The mean APACHE II score of patients who succumbed was 27, and the mean APACHE II score of the survivors was 20 (p ϭ 0.307). Two patients had leukocytosis. Six patients (four of them alcoholics) had leukopenia. The median leukocyte count was 4,760/L. Disseminated intravascular coagulopathy was noted in five patients with thrombocytopenia, prolonged prothrombin time, low fibrinogen level, and a positive result on the d-dimer test. The courses of five patients were complicated by acute renal failure. Renal function was restored in only one patient receiving treatment.
Initial chest radiography showed lobar consolidation involving one (n ϭ 8) or more (n ϭ 4) lobes (Fig  1) . Only one patient had interstitial infiltrates rather than lobar consolidation. Rapid progression of infiltrates from a single lobe to the entire lung in the first 24 h occurred in two patients. Two patients developed cavitary lesions, and four patients had pleural effusions. A baumannii grew in the pleural effusions of two patients. The empyema was drained by chest tube. The pleural effusion of patient 2 was a sterile, neutrophil-predominant exudate.
Cultures of sputum specimens from 9 of 13 patients were positive for A baumannii. Sputum smears (obtained from only three patients) revealed no microorganisms in patient 2, Gram-positive diplococci and Gram-negative bacilli in patient 5, and Gram-positive coccobacilli in patient 13. A smear of pleural effusion from patient 13 was also interpreted as showing Gram-positive coccobacilli; however, culture of sputum and pleural effusion from patient 13 both yielded A baumannii (a Gram-negative rod). Thus the seemingly Gram-positive coccobacilli in smears were probably improperly destained Acinetobacter.
Eight of the 11 patients in shock or respiratory failure who were admitted to the ICU died. The cause of death was septic shock in three patients and multiple organ failure in five patients. The two patients who were admitted to general ward survived, resulting in an overall mortality of 62%. Although each was associated with a mortality of 72%, shock at presentation (p ϭ 0.128) and initial respiratory failure (p ϭ 0.128) were not statistically significant indicators of poor prognosis. Similarly, *M ϭ male; F ϭ female; AF ϭ atrial fibrillation; CVA ϭ cerebrovascular accident; DM ϭ diabetes mellitus; HT ϭ hypertension; CAD ϭ coronary artery disease; LC ϭ liver cirrhosis; CHF ϭ congestive heart failure; NHL ϭ non-Hodgkin's lymphoma; RUL ϭ right upper lobe; LLL ϭ left lower lobe; RLL ϭ right lower lobe; LUL ϭ left upper lobe.
radiographic findings did not predict fatal outcome. Four of the six leukopenic patients (67%) died. The antibiotic susceptibility of A baumannii isolates is shown in Table 2 . All were susceptible to imipenem; most were susceptible to aminoglycosides (77 to 92%), quinolones (77 to 91%), extendedspectrum penicillins (69 to 92%), and ceftazidime (69%). The isolate from patient 10 and that from patient 12 showed multiple drug resistance; the former was susceptible to imipenem and the latter to cefepime, imipenem, and amikacin only. Isolates were resistant to aztreonam (susceptibility, 0%) and to cefoperazone (8%). Four of the five patients who survived were initially treated with a cephalosporin and an aminoglycoside, but only one of the eight patients who died received this treatment (p ϭ 0.169).
Discussion
Although A baumannii is not a well-recognized pathogen causing CAP, its importance increases in warm and humid countries, as shown by its identification in 10% of all community-acquired bacteremic pneumonia and 21% of Gram-negative pneumonia in northern Australia, 6 and by the preponderance of case reports of A baumannii CAP from countries in tropical or subtropical regions (Australia, 6 Kuwait, 7 Turkey, 10 Taiwan, 11 Thailand, 19 and Papua New Guinea 20 ). It is also more prevalent in warm and humid months of the year, inasmuch as 11 of 13 patients in our study acquired the infection between April and October. Even in temperate regions, its occurrence has shown a clear seasonal variation. All the patients described in the literature with known month of occurrence, including those from Europe and North America, acquired the infection between April and October. 7, 9, 10, [21] [22] [23] [24] [25] [26] The seasonal increase in prevalence probably reflects the inclination of Acinetobacter for warm and humid environments. 27 The pneumonia frequently occurred in alcoholic patients, as 31% of patients in our study and 46% in previous case reports are alcoholics. 6 Our study suggested that among alcoholics, young alcoholics were more susceptible. Fulminant course was another characteristic presentation, with acute onset of dyspnea, cough, and fever that rapidly progressed to respiratory failure and shock. Leukopenia was com- Piperacillin mon. A similarly rapid, fulminant course has also been observed in CAP due to Streptococcus pneumoniae 28, 29 as well as Klebsiella pneumoniae, 30, 31 with leukopenia being a sign of poor prognosis, and alcoholism a common comorbidity. Differentiation from CAP due to other bacteria can be difficult. The isolation of A baumannii from sputum in 69% of our patients suggests that a good sputum smear, defined as a Gram stain smear of an adequate sputum specimen that comes from the lower respiratory tract and contains Ͼ 25 leukocytes per high-power field (100ϫ) on microscopic examination, may help the initial diagnosis. Although Acinetobacter species is often misinterpreted as Gram-positive cocci owing to its tendency to retain crystal violet on Gram's staining, 24 as seen in one patient of this series, an experienced microbiologist can make the proper staining and interpretation. Strains of A baumannii causing community-acquired infections are usually susceptible to aminoglycosides, extended-spectrum penicillins, ceftazidime, quinolone, and imipenem. 6, 9 Although only 69% of the Acinetobacter isolates in our study were susceptible to ceftazidime, and only 77% were to gentamicin, four of the five survivors were initially treated with a third-generation cephalosporin plus an aminoglycoside, including one patient whose isolate was resistant to both ceftazidime and gentamicin (patient 10). Previous studies 32, 33 in Pseudomonas aeruginosa and K pneumoniae have suggested that empirical combination therapy with a ␤-lactam and an aminoglycoside may be associated with the best outcome for bacteremic infections, particularly in severely ill patients. It seems that an empirical combination therapy may also be appropriate for bacteremic Acinetobacter pneumonia.
The mortality of community-acquired A baumannii pneumonia in our study (62%) and that in the previous reports (40 to 64%) 6 were higher than the overall mortality (24%) resulting from severe CAP in a prospective study. 13 One of the possible reasons could be the method we chose for recruiting patients, as only those with positive blood or pleural effusion culture findings were included. The mortality reported here is comparable to those reported for severe CAP due to S pneumoniae (40 to 75%), Legionella pneumophila (33 to 56%), or Staphylococcus aureus (72 to 100%) in the Nottingham series. 14 
Conclusion
A baumannii is an uncommon but important cause of severe CAP, especially in tropical/subtropical regions and other places with warm and humid seasons. It should be highly suspected in patients (especially young alcoholic patients) who present with a rapidly progressive, fulminant course. A good sputum smear may help to make an early diagnosis. The combination of a third-generation cephalosporin and an aminoglycoside may be an appropriate empirical therapy.
